Evidence map›Paper›PMID 40905079›Full record

ArticleHaematologica2026

The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study.

Michael A Bauer, Phillip Farmer, Joseph L Su, Mario Schootman, Chenghui Li, Frits Van Rhee, Samer Al Hadidi, Carolina Schinke, John D Shaughnessy, Fenghuang Zhan and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael A BauerDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR. mbauer2@uams.edu.
Phillip FarmerDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR.
Joseph L SuUniversity of Texas Southwestern Medical Center, Dallas, TX.
Mario SchootmanDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
Chenghui LiDivision of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, AR.
Frits Van RheeDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
Samer Al HadidiDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
Carolina SchinkeDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
John D ShaughnessyDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
Fenghuang ZhanDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
Cody AshbyDepartment of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR. TCAshby@uams.edu.

Funding

Prevention of MGUS Progression to MM by Modulating the Bone Marrow MicroenvironmentU54CA272691 · NCI · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Yong Li · 2023 to 2026
$6.1M
Towards a better understanding of the critical role and therapeutic potential of drug resistant genes in multiple myelomaR01CA236814 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI FENGHUANG ZHAN · 2020 to 2026
$2.5M
BLRD VA I01 BX006235NCI NIH HHS R01 CA236814NCI NIH HHS U54 CA272691
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40905079
PMCPMC12862332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.